No coverage is required under §§ 58-17-100 to 58-17-106, inclusive,
for the following:
Any drug that has not been fully licensed or approved by the FDA;
The use of any drug if the FDA has determined that use to be contraindicated; or
Any experimental drug not otherwise approved for any indication by the FDA.
SL 2000, ch 242, § 3.